作者
Michael D Dake, Dierk Scheinert, Gunnar Tepe, Jörg Tessarek, Fabrizio Fanelli, Marc Bosiers, Christof Ruhlmann, Zaza Kavteladze, Aaron E Lottes, Anthony O Ragheb, Thomas Zeller
发表日期
2011/10
期刊
Journal of Endovascular Therapy
卷号
18
期号
5
页码范围
613-623
出版商
SAGE Publications
简介
Purpose
To report a prospective, single-arm, multicenter clinical study evaluating the Zilver PTX drug-eluting stent for treating the above-the-knee femoropopliteal segment (NCT01094678; http://www.clinicaltrials.gov).
Methods
The Zilver PTX drug-eluting stent is a self-expanding nitinol stent with a polymer-free paclitaxel coating. Patients with symptomatic (Rutherford category 2–6) de novo or restenotic lesions (including in-stent stenosis) of the above-the-knee femoropopliteal segment were eligible for enrollment. Between April 2006 and June 2008, 787 patients (578 men; mean age 66.6±9.5 years) were enrolled at 30 international sites.
Results
Nine hundred lesions (24.3% restenotic lesions of which 59.4% were in-stent stenoses) were treated with 1722 Zilver PTX stents; the mean lesion length …
学术搜索中的文章
MD Dake, D Scheinert, G Tepe, J Tessarek, F Fanelli… - Journal of Endovascular Therapy, 2011